β‐Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In‐Hospital and 12‐Month Outcome: Results From the GULF‐RACE 2 (Gulf Registry of Acute Coronary Events‐2)

BACKGROUND: The prognostic impact of β‐blockers (BB) in acute coronary syndrome (ACS) patients without heart failure (HF) or left ventricular dysfunction is controversial, especially in the postreperfusion era. We sought to determine whether a BB therapy before admission for ACS has a favorable in‐h...

Descripción completa

Detalles Bibliográficos
Autores principales: Abi Khalil, Charbel, AlHabib, Khalid F., Singh, Rajvir, Asaad, Nidal, Alfaleh, Hussam, Alsheikh‐Ali, Alawi A., Sulaiman, Kadhim, Alshamiri, Mostafa, Alshaer, Fayez, AlMahmeed, Wael, Al Suwaidi, Jassim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779059/
https://www.ncbi.nlm.nih.gov/pubmed/29263035
http://dx.doi.org/10.1161/JAHA.117.007631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779059/
https://www.ncbi.nlm.nih.gov/pubmed/29263035
http://dx.doi.org/10.1161/JAHA.117.007631

Ejemplares similares